GENE ONLINE|News &
Opinion
Blog

Novo Nordisk
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Long Standing Rivalry in Diabetes Market Intensifies as Eli Lilly’s Drug Outshines Novo’s in Head to Head Trial
2021-03-05
Study Shows New Diabetes Drug Induces Remarkable Weight Loss in Obese Patients
2021-02-15
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
Novo Nordisk’s Acquisition of Emisphere Could Embolden Diabetics to Cut Back on Needles
2020-11-08
Weekly Top 5 in China (0310-0316)
2019-03-19
Novo Nordisk Pharma Ltd. Partners with Health2Sync in Japan, Bringing Digital Diabetes Management to Healthcare Providers and Patients
2019-03-05
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!